Riskpilot← Back to searchSign inGet full accessTE Consult Mariefred AB
ABActiveOrg 5592526916Gnejsvägen 11Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20200 employees
Revenue 2025
SEK 213K
+67% vs 2024
EBITDA margin
-2.8%
-120% vs 2024
Equity ratio
29.7%
Financial strength
Net profit 2025
SEK -7K
-192% vs 2024
| Revenue | SEK 213K | +67% |
| EBITDA | SEK -6K | -120% |
| Net profit | SEK -7K | -192% |
| Total assets | SEK 69K | -49% |
| Equity | SEK 20K | -26% |
| Employees | 0 | — |
Legal name
TE Consult Mariefred AB
Org number
5592526916
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
20 april 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Företaget skall bedriva försäljning och behandling av medicinsk utrustning samt konsultation inom hälsa, behandling med elektromagnetiska impulser för att främja vasomotion i microkärlen. Företaget skall bedriv försäljning och installation av säkerhetsprodukter larm, kameraövervakning och eltekniska lösningar. Företaget skall bedriva försäljning och montering av solskyddsprodukter markiser, persienner och dylikt.Företaget kommer också konsultera hundägare i olika former av hunddressyr, samt erhålla försäljning av hundtillbehör, foder & tillskott.
Address
Gnejsvägen 11
Email
mr_pte@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 27 | 287 | 128 | 213 |
| Staff expenses | — | −26 | −27 | −0 | −4 |
| EBITDA | 2 | −18 | 42 | 29 | −6 |
| Depreciation & amort. | −14 | −18 | −21 | −21 | — |
| EBIT | −12 | −37 | 21 | 8 | −6 |
| Net financials | — | −0 | −2 | −1 | −1 |
| Profit before tax | −12 | −37 | 19 | 8 | −7 |
| Tax | −0 | — | — | — | — |
| Net profit | −12 | −37 | 19 | 8 | −7 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 88 | 106 | 102 | 134 | 69 |
| Equity | 13 | 1 | 20 | 27 | 20 |
| Long-term debt | 37 | 42 | 41 | 0 | — |
| Short-term debt | 38 | 63 | 41 | 107 | 48 |
| Total debt | 75 | 105 | 82 | 107 | 48 |
EBITDA margin
-2.8%
This company
15.8%
Market median
-118% vs market
20212025
Equity ratio
29.7%
This company
38.2%
Market median
-22% vs market
20212025
Return on equity
-34.5%
This company
18.4%
Market median
-288% vs market
20212025
Net profit margin
-3.3%
This company
8.1%
Market median
-141% vs market
20212025
Asset turnover
3.11×
This company
1.12×
Market median
+178% vs market
20212025
Debt / equity
2.37×
This company
0.62×
Market median
-282% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-04-01 – 2024-03-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-04-01 – 2021-03-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2024 | |
| Chairman | 2022 | |
| Board of Directors | 2024 | |
| Former (1) | ||
| Board of Directors | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of TE Consult Mariefred AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mari Susann Arnlund | Board of Directors | 0 companies |
| Per Anders Eriksson | Deputy Board Member | 0 companies |
| Per Tommy Eriksson | Chairman | 0 companies |
| Gittan Maria Ericsson | Board of Directors | 0 companies |